696 results on '"Domènech E"'
Search Results
2. A steganographic approach based on the chaotic fractional map and in the DCT domain
3. Prediction of peritoneal soiling in acute appendicitis with simple clinical and laboratory data. Prospective, multicenter, cohort study of 2,645 adult patients nationwide
4. Hiding data inside images using orthogonal moments
5. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry
6. The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
7. Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery. Prospective, multicenter, observational cohort study
8. A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection
9. Is Hospital Admission Essential? Evaluation of Immediate Postoperative Care and Adverse Events Following Endoscopic Peroral Myotomy (POEM) for achalasia
10. P230 Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry
11. P168 Specialized pro-resolving lipid mediator Resolvin D1 and omega 6 dihomo-γ-linolenic acid are unable to solve inflammation in the creeping fat of patients with severe postoperative recurrence in Crohn's disease
12. OP37 Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU
13. N33 Experience of inflammatory bowel disease patients in relation to the practice of anal intercourse
14. P081 The integration of transcriptomic and microbiomic data links several intestinal bacterial families with key biological functions in the development of postoperative recurrence in Crohn's disease
15. P022 Development of a novel experimental model for studying creeping fat in Crohn's Disease
16. P419 Proximal Crohn’s disease location is associated with a more benign course of perianal Crohn’s disease (the PERIAPROX study)
17. DOP75 Frequency and effectiveness of dose escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA
18. P1115 Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study
19. P987 Impact of Crohn’s Disease Location on Biologic Therapy Persistence and the Risk of Intestinal Surgery: Insights from the ENEIDA Registry (the DISCOLOC Study)
20. Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
21. Seroprevalence of canine Leishmania infantum infection in the Mediterranean region and identification of risk factors: The example of North-Eastern and Pyrenean areas of Spain
22. Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease
23. THE ROLE OF CD5+ AS AGGRESSIVE BIOMARKER IN DIFFUSE LARGE B‐CELL LYMPHOMA
24. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con espondiloartritis asociada a enfermedad inflamatoria intestinal
25. Tratamiento de mantenimiento con azatioprina o infliximab en pacientes con colitis ulcerosa corticorrefractarios respondedores a las 3 dosis de inducción de infliximab
26. Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry
27. Performance of prognostic risk scores in urgent upper gastrointestinal hemorrhage
28. Impact of sedation on tolerance, technical and clinical success in urgent upper gastrointestinal endoscopy
29. Risk of pulmonary aspiration and associated mortality in urgent upper endoscopy with or without sedation. Retrospective analysis with propensity score matching
30. Predictors of successful discharge in upper gastrointestinal bleeding
31. Assessing comprehensive remission for Ulcerative Colitis in clinical practice : International consensus recommendations
32. Requerimientos terapéuticos en el tratamiento de mantenimiento de la proctitis ulcerosa
33. DOP17 HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry
34. P643 Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study
35. P151 Assessing comprehensive remission for Ulcerative Colitis in clinical practice: International consensus recommendations
36. P023 Immune-metabolic profiles of creeping fat in relation to degree of severity in Crohn's disease postsurgical recurrence
37. P541 Diagnosis, management, and evolution of acute pancreatitis secondary to thiopurines in patients with Inflammatory Bowel Disease: an ENEIDA registry study
38. P430 Mesalazine dose modification based on fecal calprotectin levels in ulcerative colitis patients in clinical remission
39. P905 Predictive pharmacogenetic risk of pancreatitis in Inflammatory Bowel Disease patients treated with thiopurines: a case-control study from the ENEIDA registry
40. OP37 Is the withdrawal of anti-tumour necrosis factor in inflammatory bowel disease patients in remission feasible without increasing the risk of relapse? Results from the randomised clinical trial of GETECCU (EXIT)
41. P386 Clinical presentation, management, and evolution of lymphomas in patients with Inflammatory Bowel Disease: an ENEIDA registry study
42. P634 Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry
43. P694 Long-term monitoring of post-surgical recurrence in Crohn's disease using a strategy based on the periodic determination of fecal calprotectin in patients without early postoperative recurrence
44. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la tuberculosis latente en pacientes con enfermedad inflamatoria intestinal
45. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection
46. Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa
47. Disease severity in familial cases of IBD
48. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study
49. DOP081 Genital granulomatosis in Crohn’s disease: results of the ECCO CONFER study
50. N032 Impact of pain due to subcutaneous administration of a biological drug
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.